Emily Bodnar
Stock Analyst at HC Wainwright & Co.
(1.15)
# 3,803
Out of 5,124 analysts
344
Total ratings
27.63%
Success rate
-10.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Emily Bodnar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AGIO Agios Pharmaceuticals | Maintains: Buy | $48 → $62 | $27.22 | +127.77% | 4 | Dec 24, 2025 | |
| VTVT vTv Therapeutics | Maintains: Buy | $36 → $47 | $39.99 | +17.53% | 3 | Dec 19, 2025 | |
| RCUS Arcus Biosciences | Maintains: Buy | $28 → $32 | $23.83 | +34.28% | 7 | Dec 12, 2025 | |
| OLMA Olema Pharmaceuticals | Maintains: Buy | $36 → $45 | $25.00 | +80.00% | 23 | Dec 11, 2025 | |
| ACRV Acrivon Therapeutics | Reiterates: Buy | $19 | $2.41 | +688.38% | 13 | Nov 25, 2025 | |
| ANAB AnaptysBio | Maintains: Buy | $52 → $51 | $48.48 | +5.20% | 13 | Nov 24, 2025 | |
| ARTV Artiva Biotherapeutics | Maintains: Buy | $12 → $15 | $4.29 | +249.65% | 2 | Nov 12, 2025 | |
| SANA Sana Biotechnology | Maintains: Buy | $11 → $9 | $4.07 | +121.13% | 12 | Nov 7, 2025 | |
| CNTX Context Therapeutics | Maintains: Buy | $4 → $5 | $1.47 | +240.14% | 13 | Nov 6, 2025 | |
| VTYX Ventyx Biosciences | Upgrades: Buy | $18 | $9.03 | +99.34% | 16 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $38 → $42 | $12.93 | +224.83% | 19 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $72 | $33.87 | +112.58% | 3 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.04 | +1,053.85% | 1 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $60 | $29.81 | +101.27% | 1 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.61 | - | 14 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $3.14 | +632.48% | 20 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $40 | $7.11 | +462.59% | 15 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $35 | $11.15 | +213.90% | 14 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $0.58 | +1,288.41% | 25 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $9 | $3.74 | +140.64% | 2 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $20 | $1.83 | +992.90% | 10 | Jul 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $36 | $14.19 | +153.70% | 9 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $115 | $65.20 | +76.38% | 13 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $560 → $280 | $6.83 | +3,999.56% | 17 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $2.82 | +183.69% | 6 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $4.36 | +588.07% | 7 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $1.85 | +872.97% | 15 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $183 | $3.81 | +4,692.91% | 12 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $0.59 | +1,086.44% | 14 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $1.32 | - | 5 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $0.71 | +2,429.87% | 1 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $0.66 | +4,919.01% | 14 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $3.03 | - | 1 | Apr 25, 2024 |
Agios Pharmaceuticals
Dec 24, 2025
Maintains: Buy
Price Target: $48 → $62
Current: $27.22
Upside: +127.77%
vTv Therapeutics
Dec 19, 2025
Maintains: Buy
Price Target: $36 → $47
Current: $39.99
Upside: +17.53%
Arcus Biosciences
Dec 12, 2025
Maintains: Buy
Price Target: $28 → $32
Current: $23.83
Upside: +34.28%
Olema Pharmaceuticals
Dec 11, 2025
Maintains: Buy
Price Target: $36 → $45
Current: $25.00
Upside: +80.00%
Acrivon Therapeutics
Nov 25, 2025
Reiterates: Buy
Price Target: $19
Current: $2.41
Upside: +688.38%
AnaptysBio
Nov 24, 2025
Maintains: Buy
Price Target: $52 → $51
Current: $48.48
Upside: +5.20%
Artiva Biotherapeutics
Nov 12, 2025
Maintains: Buy
Price Target: $12 → $15
Current: $4.29
Upside: +249.65%
Sana Biotechnology
Nov 7, 2025
Maintains: Buy
Price Target: $11 → $9
Current: $4.07
Upside: +121.13%
Context Therapeutics
Nov 6, 2025
Maintains: Buy
Price Target: $4 → $5
Current: $1.47
Upside: +240.14%
Ventyx Biosciences
Nov 5, 2025
Upgrades: Buy
Price Target: $18
Current: $9.03
Upside: +99.34%
Oct 30, 2025
Maintains: Buy
Price Target: $38 → $42
Current: $12.93
Upside: +224.83%
Oct 27, 2025
Maintains: Buy
Price Target: $27 → $72
Current: $33.87
Upside: +112.58%
Oct 14, 2025
Initiates: Buy
Price Target: $12
Current: $1.04
Upside: +1,053.85%
Oct 6, 2025
Assumes: Buy
Price Target: $60
Current: $29.81
Upside: +101.27%
Sep 29, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.61
Upside: -
Sep 10, 2025
Reiterates: Buy
Price Target: $23
Current: $3.14
Upside: +632.48%
Aug 27, 2025
Maintains: Buy
Price Target: $32 → $40
Current: $7.11
Upside: +462.59%
Aug 15, 2025
Upgrades: Buy
Price Target: $35
Current: $11.15
Upside: +213.90%
Aug 11, 2025
Maintains: Buy
Price Target: $12 → $8
Current: $0.58
Upside: +1,288.41%
Jul 22, 2025
Maintains: Buy
Price Target: $10 → $9
Current: $3.74
Upside: +140.64%
Jul 7, 2025
Maintains: Buy
Price Target: $40 → $20
Current: $1.83
Upside: +992.90%
Jul 1, 2025
Reiterates: Buy
Price Target: $36
Current: $14.19
Upside: +153.70%
Jun 16, 2025
Reiterates: Buy
Price Target: $115
Current: $65.20
Upside: +76.38%
Apr 16, 2025
Maintains: Buy
Price Target: $560 → $280
Current: $6.83
Upside: +3,999.56%
Apr 1, 2025
Reiterates: Buy
Price Target: $8
Current: $2.82
Upside: +183.69%
Mar 31, 2025
Reiterates: Buy
Price Target: $30
Current: $4.36
Upside: +588.07%
Mar 27, 2025
Reiterates: Buy
Price Target: $18
Current: $1.85
Upside: +872.97%
Mar 26, 2025
Reiterates: Buy
Price Target: $183
Current: $3.81
Upside: +4,692.91%
Mar 26, 2025
Reiterates: Buy
Price Target: $7
Current: $0.59
Upside: +1,086.44%
Mar 12, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.32
Upside: -
Feb 3, 2025
Reiterates: Buy
Price Target: $18
Current: $0.71
Upside: +2,429.87%
Nov 15, 2024
Reiterates: Buy
Price Target: $33
Current: $0.66
Upside: +4,919.01%
Apr 25, 2024
Reiterates: Neutral
Price Target: n/a
Current: $3.03
Upside: -